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Abstract 
Using bibliometric data from 269 Alzheimer investigators and the 167,142 researchers contained 
in their two-step collaboration network (i.e., co-authors and co-authors of co-authors), an eigen 
decomposition of the 13,254 unique Medical Subject Heading (MeSH) terms associated with the 43,736 
papers authored by the Alzheimer researchers was performed. A correspondence-analysis-based 
transformation of the data produced a bench-to-bedside translational spectrum along which each of the 
original 269 Alzheimer investigators were placed. The spectrum was found to naturally divide into two 
partitions one of which housed basic scientists while the other grouped together clinical researchers. In 
addition to the semantic partitions, two main coauthor subgroups were isolated, and the authors who were 
most central to those co-author subgroups were analyzed for their ability to bridge the “translational 
divide” which separated researchers grouped in the “bench” (i.e. basic science) partition from those in the 
“bedside” (i.e., clinical investigation) partition. If a given research community can be partitioned into 
bench and bedside components, then the possibility exists to use such a dataset to identify people who 
might be best suited to attempt to bridge the “translational divide” which often exists between those 
researchers who make scientific breakthroughs in the lab and those clinical investigators capable of 
bringing the bench discoveries to the patients in the form of clinical trials.  
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INTRODUCTION 
 
Over the last decade, the National Institutes of Health has put an increasing amount of emphasis on 
translational research in an effort to make more quickly available to humans medical breakthroughs made 
in the laboratory1. Nowhere is this desire more marked than at the NIH’s National Center for Research 
Resources (NCRR) and among the academic institutions which make up the Clinical and Translational 
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Science Award consortium2. The purpose of this study was to identify a scientometric approach which 
combined accepted social-network-analysis approaches and bibliometric datasets to determine an initial 
placing of Alzheimer’s Disease (AD) scientists on the translational spectrum and to subsequently identify 
which of those researchers were best suited to perform the role of a bridge between the worlds of basic 
and clinical science.  
 
METHODS 
The initial selection of 269 AD authors was taken from the pool of scientists evaluated as part of 
a 2009 study to rank the top 100 investigators in the AD research community3. A two-step, co-author 
network (i.e., co-authors and co-authors of co-authors) based on the papers published by the investigators 
in question from January 1, 1980 to August 18, 2009 was retrieved from BiomedExperts.com (BME) and 
converted into the standard GraphML4 format using Wayne-State-University conversion utilities. 
Extracting the Medical Subject Headings (MeSH) terms associated with the underling MEDLINE papers, 
allowed for an author-paper-concept network to be created in MultiNet5. As an analytical tool, MultiNet 
has been long used in the field of social network analysis in general and specifically within studies aimed 
at understanding the development of global virtual teams6. The resulting MultiNet dataset consisted of a 
total of 167,142 unique authors in the two-step network (generated from the initial seed of the 269 
selected AD researchers); 43,736 MEDLINE papers authored by the 269 AD investigators; and 13,254 
unique MeSH terms associated with those 43,736 papers (see Figure 1 below). Of note is the fact that the 
original raw number of MeSH terms was somewhat higher than the number reported above as concepts 
which occurred only once in the corpus of papers were deleted as they were extraneous to the task of 
determining collaboration across authors. 
 
Figure 1- High-level results of the MultiNet correspondence analysis. Author partitions are indicated by 
the red/blue color-coding of dots.   
 
The papers and concepts of the 269 AD authors where mapped such that those authors who had 
similar publications and concepts were closely aligned in Euclidean space as represented through 
MultiNet’s visualizations of the results of the underlying correspondence analysis7. When looking at the 
frequency distribution of the authors, it was observed that the 269 AD authors fell into a bimodal 
distribution with the polarity of the eigenvector splitting the authors into two partitions (see Figure 2).  
The 269 authors were then assigned a new partition value based on the side of the bimodal distribution on 
which each fell. This partition value was then imported into the co-author network node data.  Each of the 
269 authors now had a partition node variable with a value of 1 or 2. 
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Figure 2 – the bimodal nature of the coauthor network can be seen through aggregation of the two 
partitions (i.e.,“6P” and “8P”) pictured on the checkerboard plane (i.e., the far wall) in the above 
visualization. 
    
The co-author network was next limited to authors who had collaborated on a paper with at least 
one of the other 269 authors.  A longevity index (i.e., the count of the number of years a given pair of 
authors has collaborated) was calculated for all the 269 author pairs.  A subsequent refining of the data 
limited the co-author set to those authors who had at least two years of ongoing collaboration thereby 
eliminating those collaborations which had only occurred once.  MultNet’s Negopy clustering algorithm 
was run to determine the unique network subgroups and roles of the 269 authors.  The authors fell into 
two main subgroups. Within each subgroup the top 10% of authors in terms of their centrality in the co-
author network of their subgroup were selected. From this pool of the most central authors in each 
subgroup, a crosstab by partition was done to see which of the highly-central authors contributed most to 
the cross-partition collaboration. In other words, the authors who were highly collaborative within the two 
subgroups (as defined by co-author relationships) and showed the ability to bridge the two partitions 
(determined by the affinity of MeSH terms used in papers) were assessed. Virginia M.-Y. Lee, Ph.D. of 
the University of Pennsylvania was determined to be the highly-central author who provided the most 
collaborative bridging between the two semantically-divergent partitions.  
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Figure 3 – Correspondence-analysis results for Virginia M.-Y. Lee showing the breadth of 
coauthor coverage (i.e., middle band) and of MeSH coverage (i.e., right-hand band) on the translational 
spectrum. 
 
 
RESULTS 
 
In analyzing the partition values of the 269 scientists, it became patently clear that the axis along which 
MultiNet’s correspondence analysis had stratified the authors was a bench-to-bedside axis. In other 
words, by looking at the MeSH terms associated with the papers belonging to the authors at either end of 
the spectrum, it became clear that one partition (i.e. , the red partition) was made of human-subject 
oriented investigators who were characterized by MeSH terms such as “Computerized Medical Records,” 
“Urban Health Services,” and “Nontherapeutic Human Experimentation” while the other was comprised 
of basic scientists more likely to be using animals in their experimental designs and characterized by  
MeSH terms such as “Crotalid Venoms,” “Armadillo Domain Proteins,” and “Bufo marinus.”  
 If a given research community can be partitioned into bench and bedside components, then the 
possibility exists to use such a dataset to identify people who might be best suited to attempt to bridge the 
“translational divide” 8 which often exists between those researchers who make scientific breakthroughs 
in the lab and those clinical investigators capable of bringing the bench discoveries to the patients in the 
form of clinical trials. The example given above of Dr. Virgina Lee is an example of this potential. Lee 
was categorized by MultiNet as being one of the most centrally connected authors in the basic scientist 
partition. At the same time, however, Lee was identified as being the researcher who had best shown the 
ability to bridge the AD translational divide by collaborating with researchers in the bedside partition. In 
fact, if one does a PubMed search on Dr. Lee and limits the search to AD clinical trials, one finds four 
papers. In the community of AD basic scientists, it is very rare to find an investigator with any papers that 
have been officially tagged in MEDLINE as having reported on the results of a clinical trial.        
 
 
CONCLUSIONS 
 
 The approach used in this study to automatically stratify AD investigators along the bench-to-
beside spectrum appears to be a reliable and reproducible approach that can be used to group investigators 
within any biomedical research community.  
An interesting direction for future research is that of refining the ability to identify those 
researchers most likely to contribute to the bridging of the translational divide. If a list of such 
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investigators could be communicated to decision makers who were in the process of pulling together 
translational research teams, then empirical studies might be done to assess the ability of this approach in 
helping with the identification of potential linchpin members of translational teams.  
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